Using of Irradiated Amnion Dressing for the Treatment of Skin Ulcer

NCT ID: NCT03440528

Last Updated: 2023-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-02-02

Study Completion Date

2018-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the using of a commercial product of dried human amniotic membrane sterilized by gamma irradiation for the treatment of skin ulcer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dried human amniotic membrane patches were obtained from National center for radiation research and technology, Egypt, under commercial name REGE pro.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients have unhealing ulcer

Exclusion Criteria

* must stop other line of treatment
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Waleed Nemr,Egyptian Atomic Energy Authority

UNKNOWN

Sponsor Role collaborator

Egyptian Atomic Energy Authority

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nashwa Radwan

Lecture of Dermatology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nashwa K Radwan, PhD

Role: STUDY_DIRECTOR

NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amniotic tissue lab

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

29112017NCRRT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Albumin Use in Burn Patients
NCT00609414 COMPLETED
Dilute Bleach Compresses for Radiation Dermatitis
NCT04851522 WITHDRAWN EARLY_PHASE1